Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

982 recalls · Class II, newest first

Class II · Moderate risk

Actoplus met XR

Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.

Terminated Packaging defect Takeda Development Center Americas, Inc. D-0026-2019
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6675-8 D-1210-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6625-8 D-1209-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6650-8 D-1208-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6610-8 D-1207-2018
Class II · Moderate risk

Tizanidine HCl Tablets

Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-179-15 D-1191-2018

Recalls by year